Integrated In Silico and In Vitro Evaluation of Trillium govanianum Metabolites against Key Protein Targets in Non‐Small Cell Lung Cancer
Open Access
- 10 November 2026
- journal article
- research article
- Published by Wiley in ChemistrySelect
- Vol. 11 (42) , e75125
Abstract
Trillium govanianum was investigated for its potential anti‐lung cancer activity against Non‐small cell lung cancer (NSCLC) using an integrated metabolomic, computational, and experimental approach. Ultra‐performance liquid chromatography coupled with electrospray ionization‐mass spectrometry (UPLC‐ESI‐MS) profiling of petroleum ether (PE), hexane (Hex), ethyl acetate (EtOAc), and methanol (MeOH) extracts putatively annotated bioactive metabolites, including Diosgenin, Pennogenin E, Govanoside A, Trillarin, Polyphyllin VII, and Sarsasapogenin. Network pharmacology analysis integrated NSCLC associated targets from multiple databases with predicted metabolite targets, revealing 374 overlapping targets associated with NSCLC. Protein‐protein interaction analysis identified EGFR, SRC, VEGFA , and STAT3 as major hub proteins involved in cancer progression. Molecular docking studies demonstrated strong binding affinities of the metabolites toward these targets, with Govanoside A showing the highest affinity for EGFR (−11.3 kcal/mol) through multiple hydrogen bond interactions. In vitro cytotoxicity testing on A‐549 lung cancer cells showed that the MeOH extract exhibited the strongest anticancer activity, reducing cell viability to approximately 35% at 500 µg/mL. Furthermore, all metabolites displayed favorable, ADMET characteristics and satisfied Lipinski's Rule of Five. Overall, these findings suggest that T. govanianum possesses promising multi‐target therapeutic potential against NSCLC, potentially through the modulation of the EGFR, SRC, VEGFA , and STAT3 signaling pathways.Keywords
This publication has 83 references indexed in Scilit:
- Elevation‐Driven Variation in Chemical Composition and Biological Activities of Rhododendron anthopogon Essential Oil: A Case Study From the HimalayaChemistry & Biodiversity, 2026
- Developmental Stage‐Wise Phytochemical Characterization and Biological Evaluation of Saponin‐Enriched Fractions From Trillium govanianum RhizomesChemistry & Biodiversity, 2025
- Metabolic Profiling and Antibacterial Activity of Carissa opaca Leaf Extracts: Bridging Experimental and Computational ApproachesChemistry & Biodiversity, 2025
- Chemodiversity and Biological Properties of Endangered Medicinal Herb Trillium govanianum along Himalayan Elevation GradientChemistry & Biodiversity, 2025
- Exploring Steroidal Saponin Composition and Morphometric Characteristics of Rhizomes from Trillium govanianum Wall. ex D. Don: Inference for Medicinal Properties and Genetic Stock ImprovementChemistry & Biodiversity, 2024
- Lung cancer statistics, 2023Cancer, 2024
- Biochemical, Toxicological, and in Silico Aspects of Trillium govanianum Wall. ex D.Don (Trilliaceae): A Rich Source of Natural Bioactive CompoundsChemistry & Biodiversity, 2023
- Src signaling in cancer invasionJournal of Cellular Physiology, 2010
- Diosgenin targets Akt‐mediated prosurvival signaling in human breast cancer cellsInternational Journal of Cancer, 2009
- Using AutoDock for Ligand‐Receptor DockingCurrent Protocols in Bioinformatics, 2008